SPK Acquisition Corp. (NASDAQ:SPK) announced in an 8-K this morning that it has terminated its combination agreement with Varian Bio and will instead liquidate on December 29.
The SPAC did not make a required $50,000 contribution to trust on December 10 to extend its transaction deadline and on December 21 gave notice that it would terminate the merger, citing breaches by Varian of one or more of the deal’s terms.
Without the extension payment, SPK was required to liquidate as soon as practicable. It has not yet released an official redemption rate, but it is estimated to have $10.41 per share in its trust.
An earlier extension vote on September 9 saw 79.6% of its shares redeemed, whittling its trust down to about $10.8 million. SPK was only required to maintain more than $5 million in cash available to meet the deal’s conditions, but the combination had already been pending for more than 10 months since its announcement on February 14.
Westport, Connecticut-based Varian Bio is developing two novel therapeutics using aPKCi inhibitors to attempt to impede tumor growth in basal cell carcinomas, the most common cancer type in the world.
This had already been a long road from SPK’s IPO on June 8, 2021 with a nine-month initial clock. This may not mark the end of the story as the transaction stipulates that if the deal was terminated as the result of a breach by either party, that side would owe the other a $2.2 million breakup fee.
Nonetheless, the liquidation is set to occur at the close of business on December 29, with all of SPK’s rights expiring worthless.
Terms Tracker for the Week Ending May 2, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. April wrapped with some real momentum. Over the course of the month, 19 SPACs filed new S-1s, while 12 IPOs priced. Furthermore, nine deal announcements...
ProCap Acquisition Corp. (NASDAQ:PCAPU) has filed for a $200 million SPAC to hunt for a fintech or financial services target. The new S-1 filing was BTIG’s second of the week after a two-month break, bringing its 2025 new SPAC filings to five and the bank has so far managed to IPO five SPACs as well....
MSM Frontier Capital Acquisition Corp. (NASDAQ:MSMUU) has filed for a $225 million SPAC to search for a infrastructure target in Africa. The new SPAC will head out on this expedition with a trust that is not overfunded and units that each contain one right to a 1/8 share. It will also have 24 months to...
At the SPAC of Dawn This action-packed week in SPACs comes to an end with three more SPACs launching their IPOs, bringing it to nine on the week. And, the crypto strategy that SPACInsider noticed becoming increasingly popular among de-SPACs earlier this year has continued to gain steam. This week, edtech firm Classover (NASDAQ:KIDZ), fresh...
Cartesian Growth Corporation III (NASDAQ:CGCT) announced the pricing of its upsized $240 million IPO and its shares are expected to begin trading on the Nasdaq under the symbol “CGCT”, Friday, May 2, 2025. The new SPAC intends to combine with a closely held private company ready to make the jump to being a market-leading transnational...